Skip to main content

Table 1 Baseline characteristics

From: Lauren classification combined with HER2 status is a better prognostic factor in Chinese gastric cancer patients

  Lauren classification P# value HER2 status P* value
Diffuse(%) Intestinal(%) Mixed(%) Negative(%) Positive(%)
Sex     <0.0    
Male 242 (43.7) 216 (39.0) 96 (17.3) 01 486 (87.7) 68 (12.3) 0.176
Female 185 (64.7) 68 (23.9) 31 (10.9) 258 (90.8) 26 (9.2)
Age     <0.001    <0.001
≤59 269 (62.7) 104 (24.2) 56 (13.1) 398 (92.8) 31 (7.2)
>59 158 (38.6) 180 (44.0) 71 (17.4) 346 (84.6) 63 (15.4)
Stage     <0.001    0.406
I 68 (47.9) 60 (42.3) 14 (9.8) 131(92.3) 11 (7.7)
II 96 (41.7) 102 (44.3) 32 (13.9) 203 (88.3) 27 (11.7)
III 215 (56.9) 95 (25.1) 68 (18.0) 335 (88.6) 43 (11.4)
IV 48 (54.5) 27 (30.7) 13 (14.8) 75 (85.2) 13 (14.8)
Degree of differentiation     <0.001    <0.001
Well + Moderate 0 (0) 262 (76.2) 82 (23.8) 270 (78.5) 74 (21.5)
Poor + signet ring cell 427 (86.4) 22 (4.5) 45 (9.1) 474 (96.0) 20 (4.0)
Location     <0.001    <0.001
Proximal 110 (35.9) 146 (47.7) 50 (16.3) 251 (82.0) 55 (18.0)
Distal 276 (59.1) 128 (27.4) 63 (13.5) 436 (93.4) 31 (6.6)
Total stomach 41 (63.1) 10 (15.4) 14 (21.5) 57 (87.7) 8 (12.3)
Adjuvant chemotherapy        
Yes 302 (51.4) 192 (32.7) 94 (15.9)   531 (90.3) 57 (9.7)  
No 77 (47.5) 65 (40.1) 20 (12.4) 0.170 138 (85.2) 24 (14.8) 0.063
  1. HER2: human epidermal growth factor receptor 2.
  2. #P values of Lauren classification in different clinical features. *P values of HER 2 status in different clinical features.
\